96 related articles for article (PubMed ID: 23262423)
21. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
Cao W; Zhou J; Mann A; Wang Y; Zhu L
Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
[TBL] [Abstract][Full Text] [Related]
22. Folate receptor-targeted lipid-albumin nanoparticles (F-LAN) for therapeutic delivery of an Akt1 antisense oligonucleotide.
Li H; Liu Y; Chen L; Liu Q; Qi S; Cheng X; Lee YB; Ahn CH; Kim DJ; Lee RJ
J Drug Target; 2018; 26(5-6):466-473. PubMed ID: 29376449
[TBL] [Abstract][Full Text] [Related]
23. Mannose 6-phosphate-modified bovine serum albumin nanoparticles for controlled and targeted delivery of sodium ferulate for treatment of hepatic fibrosis.
Li FQ; Su H; Chen X; Qin XJ; Liu JY; Zhu QG; Hu JH
J Pharm Pharmacol; 2009 Sep; 61(9):1155-61. PubMed ID: 19703364
[TBL] [Abstract][Full Text] [Related]
24. [Research progress on pharmacology, pharmacokinetics and determination of ergosta-4,6,8 (14),22-tetraen-3-one].
Chen H; Chen DQ; Li QF; Li PF; Chen H; Zhao YY
Zhongguo Zhong Yao Za Zhi; 2014 Oct; 39(20):3905-9. PubMed ID: 25751937
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of (99m)Tc-DO3A-EA-Folate for receptor-mediated targeting of folate positive tumors.
Mishra G; Hazari PP; Kumar N; Mishra AK
J Drug Target; 2011 Nov; 19(9):761-9. PubMed ID: 21425922
[TBL] [Abstract][Full Text] [Related]
26. Folate targeting enables durable and specific antitumor responses from a therapeutically null tubulysin B analogue.
Leamon CP; Reddy JA; Vetzel M; Dorton R; Westrick E; Parker N; Wang Y; Vlahov I
Cancer Res; 2008 Dec; 68(23):9839-44. PubMed ID: 19047164
[TBL] [Abstract][Full Text] [Related]
27. Folate-modified bexarotene-loaded bovine serum albumin nanoparticles as a promising tumor-targeting delivery system.
Qi L; Guo Y; Luan J; Zhang D; Zhao Z; Luan Y
J Mater Chem B; 2014 Dec; 2(47):8361-8371. PubMed ID: 32262006
[TBL] [Abstract][Full Text] [Related]
28. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
29. In vitro control release, cytotoxicity assessment and cellular uptake of methotrexate loaded liquid-crystalline folate nanocarrier.
Misra R; Upadhyay M; Perumal V; Mohanty S
Biomed Pharmacother; 2015 Feb; 69():102-10. PubMed ID: 25661345
[TBL] [Abstract][Full Text] [Related]
30. Reduced toxicological manifestations of cisplatin following encapsulation in folate grafted albumin nanoparticles.
Alam N; Dubey RD; Kumar A; Koul M; Sharma N; Sharma PR; Chandan BK; Singh SK; Singh G; Gupta PN
Life Sci; 2015 Dec; 142():76-85. PubMed ID: 26482203
[TBL] [Abstract][Full Text] [Related]
31. Folate-conjugated methoxy poly (ethylene glycol)/poly (L-Alanine) amphiphilic block copolymeric micelles for targeted delivery of paclitaxel.
Jiao Z; Wang X; Chen Z
Drug Deliv; 2011; 18(7):478-84. PubMed ID: 21675929
[TBL] [Abstract][Full Text] [Related]
32. [Study on the preparation of folate-conjugated albumin nanoparticles].
Zhang L; Hou S; Mao S; Song X; Chen T
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Apr; 21(2):225-8. PubMed ID: 15143545
[TBL] [Abstract][Full Text] [Related]
33. [Tumor cell targetability of folate receptor-mediated mitoxantrone albumin nanoparticles].
Zhang LK; Hou SX; Mao SJ; Wei DP; Song XR
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):77-9. PubMed ID: 16468648
[TBL] [Abstract][Full Text] [Related]
34. Preparation of folate-modified pullulan acetate nanoparticles for tumor-targeted drug delivery.
Zhang HZ; Li XM; Gao FP; Liu LR; Zhou ZM; Zhang QQ
Drug Deliv; 2010 Jan; 17(1):48-57. PubMed ID: 22747075
[TBL] [Abstract][Full Text] [Related]
35. Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting.
Bansal A; Kapoor DN; Kapil R; Chhabra N; Dhawan S
Acta Pharm; 2011 Jun; 61(2):141-56. PubMed ID: 21684843
[TBL] [Abstract][Full Text] [Related]
36. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
[TBL] [Abstract][Full Text] [Related]
37. 9-NC-loaded folate-conjugated polymer micelles as tumor targeted drug delivery system: preparation and evaluation in vitro.
Han X; Liu J; Liu M; Xie C; Zhan C; Gu B; Liu Y; Feng L; Lu W
Int J Pharm; 2009 May; 372(1-2):125-31. PubMed ID: 19166923
[TBL] [Abstract][Full Text] [Related]
38. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
[TBL] [Abstract][Full Text] [Related]
39. AS1411 aptamer tagged PLGA-lecithin-PEG nanoparticles for tumor cell targeting and drug delivery.
Aravind A; Jeyamohan P; Nair R; Veeranarayanan S; Nagaoka Y; Yoshida Y; Maekawa T; Kumar DS
Biotechnol Bioeng; 2012 Nov; 109(11):2920-31. PubMed ID: 22615073
[TBL] [Abstract][Full Text] [Related]
40. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles.
Fan J; Fang G; Wang X; Zeng F; Xiang Y; Wu S
Nanotechnology; 2011 Nov; 22(45):455102. PubMed ID: 22019849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
